Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Enrolling by Invitation

Menstrual Management Using a Mobile Application in Adolescent Girls With Mild Intellectual Disabilities

NCT07016932

Conditions: Hand Hygiene, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
Locations: Selçuklu Özel Eğitim Meslek Okulu Konya, Selçuklu, Turkey (Türkiye)

View Trial Details

Enrolling by Invitation

FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS

NCT06691464

Conditions: ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University Medical Center Groningen Groningen, Provincie Groningen, Netherlands

View Trial Details

Enrolling by Invitation

Treatable Traits of Severe Asthma

NCT06811740

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Haidian, China

Beijing Luhe Hospital affiliated to Capital Medical University Beijing, Tongzhou, China

View Trial Details

Enrolling by Invitation

Clinical Trials to Evaluate Neurophysiological and Neuropsychological Effects of a Mindfulness-based Intervention

NCT06618339

Conditions: Anxiety Depression (Mild or Not Persistent), Anxiety Disorders, Behavior, +13 more
Locations: Universidad Autónoma de Baja California, Neuroscience and Cognition Laboratory Mexicali, Estado de Baja California, Mexico

View Trial Details

Enrolling by Invitation

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

NCT06245031

Conditions: AD, Alzheimer Disease, Brain Diseases, +25 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

CCT Research - Foothills Research Center Phoenix, Arizona, United States

Banner Sun Health Research Institute Sun City, Arizona, United States

Advanced Research Center, Inc Anaheim, California, United States

View all 53 locations

View Trial Details

Not Yet Recruiting

A Randomised Phase 3 Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma

NCT07736950

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

NCT07731789

Conditions: Classic Follicular Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma

NCT07719855

Conditions: Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hosiptal Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions: B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations: Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

Family-Focused Study to Support Medication for Opioid Use Disorder

NCT07451197

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

University of Wisonsin-Madison Madison, Wisconsin, United States

View Trial Details

Lymphoma, Follicular

Lymphoma, Follicular trial results

Related conditions